Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis

Marian Surmann, Sebastian Falke, Lara von Gruchalla, Birgit Maisch, Christina Uhlmann, Volker Arolt, Rebekka Lencer*

*Corresponding author for this work


There is an urgent need for a better understanding of the multidimensional factors of medication adherence attitudes in patients with psychosis in order to enhance adherence as up to 75% of patients stop or change their medication within a year. 81 patients with psychosis were assessed on symptom expression, self-stigmatization, adherence attitudes, QoL, social support and therapeutic alliance judged by patients and clinicians. Regression analyses were used to test whether better QoL, more social support and a better therapeutic alliance are associated with more positive and less negative adherence attitudes. More positive clinician input, higher state anxiety and lower levels of self-stigmatization predicted more positive adherence attitudes, while less positive collaboration with the clinician and higher levels of self-stigmatization were associated with more negative adherence attitudes. QoL and social support were unrelated to adherence attitudes. The quality of the therapeutic alliance perceived by patients appears crucial regarding their medication adherence attitudes. Thus, clinicians’ focus on psychotic symptom expression is not sufficient to achieve goal agreement. Rather, it is imperative to consider the individual subjective needs of patients as a key element for sustained therapeutic alliance.

Original languageEnglish
Article number113601
JournalPsychiatry Research
Pages (from-to)113601
Publication statusPublished - 01.2021

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis'. Together they form a unique fingerprint.

Cite this